Authors: GOREN MP HOULE JM BUSH DA LI JT NEWMAN CE BRADE WP

Citation: Mp. Goren et al., SIMILAR BIOAVAILABILITY OF SINGLE-DOSE ORAL AND INTRAVENOUS MESNA IN THE BLOOD AND URINE OF HEALTHY-HUMAN SUBJECTS, Clinical cancer research, 4(10), 1998, pp. 2313-2320

Authors: WHELAN HT BAJIC DM KARLOVITS SM HOULE JM KINDWALL EP

Citation: Ht. Whelan et al., USE OF CYTOCHROME-P450 MONOOXYGENASE-2 E1 ISOZYME INHIBITORS TO DELAYSEIZURES CAUSED BY CENTRAL-NERVOUS-SYSTEM OXYGEN-TOXICITY, Aviation, space, and environmental medicine, 69(5), 1998, pp. 480-485

Authors: BIALER M YACOBI A MOROS D LEVITT B HOULE JM MUNSAKA MS

Citation: M. Bialer et al., CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE, Epilepsia, 39(5), 1998, pp. 513-519

Authors: CORLEY RA MARKHAM DA BANKS C DELORME P MASTERMAN A HOULE JM

Citation: Ra. Corley et al., PHYSIOLOGICALLY-BASED PHARMACOKINETICS AND THE DERMAL ABSORPTION OF 2-BUTOXYETHANOL VAPOR BY HUMANS, Fundamental and applied toxicology, 39(2), 1997, pp. 120-130

Authors: HOMSY W YAN K HOULE JM BESNER JG GOSSARD D PIERCE CH CAILLE G

Citation: W. Homsy et al., PLASMA-LEVELS OF NICOTINE AND SAFETY OF SMOKERS WEARING TRANSDERMAL DELIVERY SYSTEMS DURING MULTIPLE SIMULTANEOUS INTAKE OF NICOTINE AND DURING EXERCISE, Journal of clinical pharmacology, 37(8), 1997, pp. 728-736

Authors: SPENARD J PIERCE CH HOULE JM OHAYON A LANDRIAULT H

Citation: J. Spenard et al., CARDIOVASCULAR-RESPONSE TO SIMULTANEOUS USE OF 3 SOURCES ON NICOTINE (N), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 203-203